• Bandeau Investisseurs

From 1994 to 2004, as per 99/02 referential

Balance sheet assets...

In EUR millions 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Goodwill 20.25 21.09 22.61 23.02 15.83 2.38 2.95 3.00 1.14 1.59 1.96
Fixed assets 39.17 36.45 35.53 35.91 25.73 13.41 12.94 11.60 8.87 8.24 5.92
Current assets 137.11 118.87 108.19 137.41 99.80 63.08 53.65 47.69 40.02 48.38 29.40
Inventory  52.28 46.04 43.13 51.94 33.97 19.22 17.91 15.69 13.51 18.49 9.25
Receivables 56.02 48.86 41.60 53.52 42.25 28.59 22.89 17.94 16.68 18.34 14.01
Other receivables and cash 28.81 23.97 23.46 31.95 23.59 15.28 12.85 14.06 9.82 11.55 6.14

 Balance sheet liabilities...

In EUR millions 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Shareholders' equity 53.10 42.95 40.93 49.80  42.16 19.23 16.90 15.16 13.02 12.17 11.40
Long term liabilities 32.20  34.61 39.62 42.68 21.53 19.09 13.77 10.25 7.75 10.72 6.44
Total liabilities and shareholders' equity 196.53 176.41 166.32 196.35 141.36 78.88 69.54 62.29 50.03 58.21 37.28

 Income statement...

In EUR millions 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Sales 227.74 198.58 176.10 183.62 134.29 104.92 91.42 77.96 72.10 62.07 54.17
Payroll charges 62.51 59.78 53.80 51.90 40.14 28.63 26.08 22.28 19.43 18.54 16.36
Operating profit 9.06 10.26 0.51 10.41 6.23 4.06 5.42 4.38 4.61 2.56 3.14
Net income 6.08 3.55 -1.85 5.31 4.37 3.69 3.47 3.73 1.63 1.02 1.33

 Other indicators...

In EUR millions 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Staff 1 942 1 873 1 715 1 760 1 505 1 123 1 091 1 050 613 595 538
Research & Development 35.70 28.70 33.20 34.34 28.04 19.67 14.54 13.92 12.47 11.43 10.52
Self-financing capacity 12.37 8.08 4.12 9.68 8.04 9.03 8.74 7.50 5.03 3.05 2.23
EBITDA 15.76 15.24 7.81 16.09 9.33            

 Ratios...

Percentage 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Payroll charges / sales 27% 30% 31% 28% 30% 27% 29% 29% 27% 30% 30%
Net income / sales 3% 2% -1% 3% 3% 4% 4% 5% 2% 2% 2%
Net income / shareholders' equity 11% 8% -5% 11% 10% 19% 21% 25% 13% 8% 12%
Research & Development / sales 16% 14% 19% 19% 21% 19% 16% 18% 17% 18% 19%
Bookmark and Share